Trimm 2 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bhagirathbhai R. Dholaria, MD, assistant professor of medicine in the Department of Hematology-Oncology at Vanderbilt University Medical Center, discussed findings from the phase 2 TRiMM-2 trial of talquetamab plus daratumumab in multiple myeloma.

United statesBhagirathbhair dholariaAmerican society of clinical oncology annual meetingOncology at vanderbilt university medical centerDepartment of hematologyVanderbilt university medical centerClinical oncology annualTrimm 2 trialAsco annual meeting